Oxadiazole derivatives as rho-kinase inhibitors
Номер патента: EP3728247A1
Опубликовано: 28-10-2020
Автор(ы): Alessandro Accetta, Christine Edwards, Elizabeth Anne Skidmore, Fabio Rancati
Принадлежит: Chiesi Farmaceutici SpA
Опубликовано: 28-10-2020
Автор(ы): Alessandro Accetta, Christine Edwards, Elizabeth Anne Skidmore, Fabio Rancati
Принадлежит: Chiesi Farmaceutici SpA
Реферат: The invention relates to compounds of formula (I) inhibiting Rho Kinase that are oxidazole derivatives, processes for preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. Particularly the compounds of the invention may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).
Oxadiazole derivatives as Rho-Kinase Inhibitors
Номер патента: US11578068B2. Автор: Fabio Rancati,Alessandro Accetta,Christine Edwards,Elizabeth Anne Skidmore. Владелец: Chiesi Farmaceutici SpA. Дата публикации: 2023-02-14.